ProCE Banner Activity

Redefining Precision Therapeutics in Hematologic Malignancies: Bispecific Antibodies

Slideset

Downloadable slideset from a live webinar covering the safety and efficacy of bispecific antibodies in the management of multiple myeloma and lymphoma, including recommendations for managing key adverse events.

Released: May 17, 2024

Expiration: May 17, 2025

Share

Faculty

Sherry Adkins

Sherry Adkins, MSN, ANP-C, FAAN

Advanced Practice Provider Supervisor
Department of Lymphoma/Myeloma
The University of Texas MD Anderson Cancer Center
Houston, Texas

Provided by

Provided by Partners for Advancing Clinical Education (PACE) in partnership with Practicing Clinicians Exchange, LLC and Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an education grant from Janssen Biotech, Inc. administered by Janssen Scientific Affairs, LLC.

Janssen Biotech, Inc. administered by Janssen Scientific Affairs, LLC

Partners

Clinical Care Options, LLC

ProCE Banner

Practicing Clinicians Exchange

ProCE Banner